Scienture Holdings, Inc. (SCNX) Financials

SCNX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 80.7 billion 13.8 billion
Dec. 31, 2025 84.2 billion 14.1 billion
Sept. 30, 2025 104.8 million 22.2 million
June 30, 2025 104.3 million 26.4 million

SCNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -2.9 billion 102.3 million
Dec. 31, 2025 -13.4 billion 2.1 billion
Sept. 30, 2025 -3.2 million 1.8 million
June 30, 2025 -2.0 million ?

SCNX Net Income

No data available :(

SCNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 3.5 billion - -
Dec. 31, 2025 6.7 billion - 24137
Sept. 30, 2025 355692 - 24137
June 30, 2025 15391 1.6 million 30602

SCNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 406.3 million
Dec. 31, 2025 153.5 million
Sept. 30, 2025 19.0 million
June 30, 2025 14.1 million

SCNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5 794.0 million 2.0 billion -
Dec. 31, 2025 3 2.0 billion 10.3 billion -
Sept. 30, 2025 5 169344 3.5 million -
June 30, 2025 2 843549 4.3 million -

SCNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 56.3 million 2.5 million
Dec. 31, 2025 -168699 59656
Sept. 30, 2025 590050 15429
June 30, 2025 - 15457

SCNX

Price: $0.38

52 week price:
0.24
2.60

Payout Ratio Range:
-68.72%
59.64%

Earnings Per Share: -2.70 USD

Exchange: NCM

Sector: Healthcare

Industry: Pharmaceutical Retailers

Market Capitalization: 16.4 million

Links: